Sistema Asia Capital, a corporate VC arm of Russian conglomerate Sistema that focuses on India and Southeast Asia, has named Edward Tay (pictured) as CEO.
The role was created for Tay, who will also function as a board member of the Singapore-based VC firm and a member of its investment committee. Tay previously held senior roles in British Telecom,...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.